Lucinda Victoria Jackson

Title: **Lucinda Victoria Jackson: Innovator in Pharmaceutical Processes**

Introduction:

Lucinda Victoria Jackson is a prominent inventor based in Cambridge, GB, with a remarkable track record in the field of pharmaceuticals. She has been granted two patents that showcase her expertise in developing processes for the synthesis of complex pharmaceutical compounds, which have significant implications for cancer treatment.

Latest Patents:

Jackson's latest patents include a **Pharmaceutical process for the preparation of 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-((R)-S-methylsulfonimidoyl)cyclopropyl]pyrimidin-2-yl}-1H-pyrrolo[2,3-b]pyridine and intermediates**. This patent, documented in International Patent Application WO2011154737, details the large-scale manufacturing methods for pharmaceutical compounds and their novel intermediates. Specifically, it highlights laboratorial procedures regarding the compound of Formula (I), which is pivotal in developing cancer therapies. The synthetic route for producing this compound is elaborated on within the patent, emphasizing a detailed and robust manufacturing process.

In addition, she has contributed to enhanced processes for the preparation of **4-{8-amino-3-[(2S)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}N-(pyridin-2-yl)-benzamide**. This disclosure targets improved large-scale processes tailored for the manufacturing of this specific compound and its intermediates, underscoring Jackson’s innovative approach to pharmaceutical synthesis.

Career Highlights:

Lucinda Victoria Jackson works with Acerta Pharma B.V., where she applies her expertise in developing pharmaceutical processes. Over her career, she has displayed exceptional skill in creating synthetic pathways for highly complex organic compounds, which are essential for advancing medical treatments.

Collaborations:

Throughout her career, Jackson has collaborated with notable colleagues Katie Grace Cooper and Paul Allen Bethel. Their teamwork illustrates the importance of collaboration in driving innovation and achieving breakthroughs in pharmaceutical research.

Conclusion:

Lucinda Victoria Jackson stands out as a significant contributor to the pharmaceutical industry. Her patents and innovative processes underscore her dedication to improving therapeutic options, particularly in the cancer treatment arena. Through her work at Acerta Pharma B.V., she continues to pave the way for future advancements in pharmaceutical manufacturing, demonstrating the vital role of inventors in today’s research landscape.